• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.

作者信息

Selmi S, Samuels H H

机构信息

Division of Molecular Endocrinology, New York University School of Medicine, New York 10016.

出版信息

J Biol Chem. 1991 Jun 25;266(18):11589-93.

PMID:1675637
Abstract

Thyroid hormone receptors are cellular homologues (c-erbAs) of the v-erbA oncoprotein of the avian erythroblastosis virus. Exclusive of the viral gag region, v-erbA differs from the chick c-erbA-alpha receptor by two amino acid changes N-terminal of the DNA binding domain, two amino acid changes in the DNA binding domain, nine amino acid changes in the C-terminal region corresponding to the ligand binding domain of c-erbA, and a nine-amino acid deletion near the C terminus. v-erbA does not bind thyroid hormone and when expressed in cells inhibits the activity of wild-type thyroid hormone receptors. We reported previously that mutants of chick c-erbA/thyroid hormone receptor which lack the DNA binding domain (DBD-) inhibit transcriptional activition by wild-type thyroid hormone and retinoic acid receptors (Forman, B. M., Yang, C.-R., Au, M., Casanova, J., Ghysdael, J., and Samuels, H. H. (1989) Mol. Endocrinol. 3, 1610-1626). This dominant negative activity mapped to a series of hydrophobic heptad motifs which are conserved in the C terminus of these receptors and have been suggested to play a role in receptor dimerization. In this study we show that unlike DBD- c-erbA, DBD- v-erbA does not block receptor activity, suggesting that v-erbA acts by competing for DNA response elements rather than by formation of nonfunctional v-erbA/c-erbA heterodimers. This difference in activity was localized to a single Pro to Ser change in v-erbA just N-terminal of the last heptad motif. Introduction of this Pro to Ser change into DBD- c-erbA resulted in a protein which was inactive both functionally and in blocking receptor dimer formation in vitro.

摘要

相似文献

1
Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
J Biol Chem. 1991 Jun 25;266(18):11589-93.
2
A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.一个包含亮氨酸拉链样基序的结构域介导甲状腺激素受体与视黄酸受体之间新的体内相互作用。
Mol Endocrinol. 1989 Oct;3(10):1610-26. doi: 10.1210/mend-3-10-1610.
3
Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.鉴定v-erbA和甲状腺激素受体α致癌活性及转录抑制所需的结构域。
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10668-72. doi: 10.1073/pnas.90.22.10668.
4
A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).在v-ErbA中缺失的保守C末端序列对c-ErbA(甲状腺激素受体)的生物学活性至关重要。
Mol Cell Biol. 1993 Jun;13(6):3675-85. doi: 10.1128/mcb.13.6.3675-3685.1993.
5
Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.Myb-Ets融合癌蛋白抑制甲状腺激素受体/c-ErbA和视黄酸受体功能:E26禽逆转录病毒致白血病转化的一种新作用机制。
Mol Cell Biol. 1996 Nov;16(11):6338-51. doi: 10.1128/MCB.16.11.6338.
6
Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein.
EMBO J. 1988 Aug;7(8):2425-33. doi: 10.1002/j.1460-2075.1988.tb03088.x.
7
Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.甲状腺激素受体的转录活性可能受到该受体截短形式的自身调节。
Mol Cell Biol. 1992 May;12(5):2406-17. doi: 10.1128/mcb.12.5.2406-2417.1992.
8
Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.源自甲状腺激素受体的v-erbA癌蛋白的个体发生:DNA结合结构域的改变对v-erbA功能起关键作用。
J Virol. 1991 Apr;65(4):2037-46. doi: 10.1128/JVI.65.4.2037-2046.1991.
9
Phosphorylation of the v-erbA protein is required for its function as an oncogene.
Genes Dev. 1990 Oct;4(10):1663-76. doi: 10.1101/gad.4.10.1663.
10
v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
Cell. 1990 Jun 15;61(6):1035-49. doi: 10.1016/0092-8674(90)90068-p.

引用本文的文献

1
Multiple mutations contribute to repression by the v-Erb A oncoprotein.多种突变导致v-Erb A癌蛋白发挥抑制作用。
Oncogene. 2005 Oct 13;24(45):6737-52. doi: 10.1038/sj.onc.1208826.
2
Thyroid hormone promotes the phosphorylation of STAT3 and potentiates the action of epidermal growth factor in cultured cells.甲状腺激素促进信号转导和转录激活因子3(STAT3)的磷酸化,并增强表皮生长因子在培养细胞中的作用。
Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):427-32.
3
Regulation of the mdm2 oncogene by thyroid hormone receptor.甲状腺激素受体对癌基因mdm2的调控
Mol Cell Biol. 1999 Jan;19(1):864-72. doi: 10.1128/MCB.19.1.864.
4
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.v-ErbA癌蛋白导致的白血病转化在体内需要与红系增强子持续结合并对其进行抑制。
EMBO J. 1998 Dec 15;17(24):7382-94. doi: 10.1093/emboj/17.24.7382.
5
Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.甲状腺激素受体对基因表达的组成性激活是由p53介导的抑制作用的逆转所导致的。
Mol Cell Biol. 1997 Dec;17(12):7195-207. doi: 10.1128/MCB.17.12.7195.
6
The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.甲状腺激素受体和视黄酸受体中保守的C末端第九个七肽通过影响异源二聚体而非同源二聚体的形成介导多种反应。
Mol Cell Biol. 1993 Sep;13(9):5725-37. doi: 10.1128/mcb.13.9.5725-5737.1993.
7
Mutations that alter ligand-induced switches and dimerization activities in the retinoid X receptor.改变视黄酸X受体中配体诱导开关和二聚化活性的突变。
Mol Cell Biol. 1994 Jun;14(6):4311-23. doi: 10.1128/mcb.14.6.4311-4323.1994.
8
The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms.erbA癌基因抑制视黄酸X受体和视黄酸受体的作用,但通过不同的机制来实现。
Mol Cell Biol. 1993 Oct;13(10):5970-80. doi: 10.1128/mcb.13.10.5970-5980.1993.
9
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR.未结合配体的T3R而非其致癌变体v-erbA,通过消耗RXR来抑制RAR依赖性反式激活。
EMBO J. 1993 Apr;12(4):1343-54. doi: 10.1002/j.1460-2075.1993.tb05779.x.
10
Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor.甲状腺激素和视黄酸受体与一种抑制性细胞因子的配体依赖性解离的功能证据。
Mol Cell Biol. 1994 Sep;14(9):5756-65. doi: 10.1128/mcb.14.9.5756-5765.1994.